UC Irvine awarded $18 million to lead groundbreaking dementia study
UCI MIND secures major NIH funding to pioneer research into LATE, a common but underrecognized brain disease affecting older adults.
Clinical Scorecard: UC Irvine awarded $18 million to lead groundbreaking dementia study
At a Glance
| Category | Detail |
|---|
| Condition | Limbic predominant age-related TDP-43 encephalopathy (LATE) |
| Key Mechanisms | Neurodegenerative disease with distinct pathology mimicking Alzheimer's |
| Target Population | Older adults aged 85 and above |
| Care Setting | Multi-center study across federally funded Alzheimer’s Disease Research Centers |
Key Highlights
- UCI MIND awarded $18 million grant for LATE study
- Study aims to establish trial-ready cohort for LATE
- Participants will undergo annual MRIs, blood draws, and PET scans
- Involves remote cognitive tests conducted at home
- Collaboration with experts in AI and informatics
Guideline-Based Recommendations
Diagnosis
- Develop reliable diagnostic tools for LATE
Management
- Identify and validate biomarkers for LATE
Monitoring & Follow-up
- Conduct annual assessments including MRIs and cognitive tests
Risks
- LATE present in up to 40% of older adults
Patient & Prescribing Data
Older adults aged 85 and above
Focus on establishing biomarkers and diagnostic criteria
Clinical Best Practices
- Engage diverse populations in research
- Utilize advanced technology for cognitive assessments
- Collaborate across disciplines for comprehensive study design
References
